Go to Page # Page of 28

iPSC-Derived Primary Cells: Expand Your Cell-Based Assays

 Yalin Firinci
Description: ATCC iPSCs were used as feedstock for this project. ATCC developed proprietary methods for the differentiation of CD34+ cells, Monocytes, and MSCs from normal human iPSCs.
Views: 1055
Domain: Medical
Category: Biotech/Pharma
Contributing Organization: ATCC
 ‐ More of their Presentations
iPSC-derived primary cells: Expand
your cell-based assays with an
unlimited, biologically relevant source
Yalin Firinci, M.B.A.
Product Line Business Specialist, ATCC

Credible Leads to Incredible™

ATCC today
 Founded in 1925, ATCC is a non-profit organization with HQ in Manassas, VA and an R&D
& Services center in Gaithersburg, MD
 World wide brand name and quality recogni ... See more

Recent Presentations

01 October, 2019
30 September, 2019
28 September, 2019